Programme subject to change. All session times are listed in Europe/Rome Time Zone (CET) (UTC+1).
-
Friday, Nov 13th
15:15 - 16:45 CETHot Topic: From Urethra to Groin - High-Stakes Decisions in Rare GU CancersChair: – Moffitt Cancer Center
-
Friday, Nov 13th
15:18 - 15:31 CETPrimary Urethral Carcinoma in 2026: Staging and Multimodality PathwaysSpeaker: – Moffitt Cancer Center
-
Friday, Nov 13th
15:31 CETDebate: “This House would perform pelvic lymph node dissection (rather than adjuvant pelvic radiotherapy/chemoradiotherapy or observation) for non-suspicious pelvic nodes but high-risk node-positive penile cancer after ILND.”Moderator: – University of Sydney
-
Friday, Nov 13th
15:31 - 15:41 CETForSpeaker: – St George's University Hospitals
-
Friday, Nov 13th
15:41 - 15:51 CET
-
Friday, Nov 13th
15:51 - 15:56 CET
-
Friday, Nov 13th
15:56 - 16:11 CETNew Developments in Systemic Therapy & Biomarkers in Penile Cancer: What’s Actionable Now and Who Should Go to Trials
-
Friday, Nov 13th
16:11 - 16:41 CETPenile Cancer Interactive Case ClinicModerator: – Tata Memorial Hospital, Homi Bhabha National Institute
-
Friday, Nov 13th
16:41 - 16:45 CET